We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Biomarker-Driven Oncology Trials.
- Authors
Makosiej, Frank; Dalton, William
- Abstract
The article presents information on the upcoming trend of biomarker-driven clinical trials to increase personalized medicines discovery and delivery. It mentions that the drug development services provider Covance Inc. has increased its services to help sponsors in conducting biomarker-driven oncology trials. It informs that Covance Inc. have partnership with the cancer-focused data warehouse company M2Gen in order to identify patients for oncology trials.
- Subjects
BIOMARKERS; CLINICAL trials; INDIVIDUALIZED medicine; COVANCE Inc.; M2GEN (Company); CANCER patients
- Publication
Applied Clinical Trials, 2013, Vol 22, Issue 5, p6
- ISSN
1064-8542
- Publication type
Article